Short interest for Rivernorth Opps Fund gives investors a sense of the degree to which investors are betting on the decline of Rivernorth Opps Fund's stock. Short interest data is updated every two weeks.

Rivernorth Opps Fund Stock (NYSE:RIV), Short Interest Report

Rivernorth Opps Fund

Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.

budding-h3PWUqxpP_0-unsplash(31)

Cannabis

News

Entrepreneurship

Retail Sales

CNPOF

CSE:RIV

CSE:TRUL

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

RIGHT ON BRANDS INC by Right On Brands, Inc.

RTON

TCNNF

TRUL

TSX:CURA

VRNOF

The cannabis revolution continues to grow with new dispensary openings across seven states. In Texas, Right on Brands and Texas Original launched new retail locations, while New York welcomed RIV Capital and Etain&#39;s new co-located dispensary. NYC Bud in Long Island City offers a unique subway-themed shopping experience. Additionally, CODES opened a new pop-up in Missouri, Curaleaf relocated its Phoenix Airport dispensary in Arizona, Sweetspot Farms launched a new store in Connecticut, Trulieve Cannabis Corp. expanded in Florida, and Verano Holdings Corp. added Zen Leaf Norristown to its Pennsylvania locations. These latest openings underscore the increasing acceptance and accessibility of cannabis products for both medical patients and recreational consumers nationwide.

Here&#39;s Where To Buy Legal Weed: Seven States Open New Cannabis Dispensaries

cannabis New York (Kindel Media by Pixabay and Quintin Gellar by Pexels)(9)

Regulations

Politics

Markets

ACRDF

THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC.

CBSTF

CRLBF

CSE:ACRG

CSE:CL

&#39;New York is going to rapidly become the largest cannabis market in the country,&#39; say cannabis companies getting ready to jump in.The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP), formerly Columbia Care, was approved Friday by the New York Office of Cannabis Management (OCM) for adult-use wholesale distribution.

These Companies Are Taking Center Stage As New York Cannabis Scene Expands

Entertainment

Penny Stocks

Topics

Success Stories

Startups

Small Business

Exclusives

Media

General

House of Puff’s new collaboration and exhibition with the author, social justice advocate and artist, Chris Wilson is opening on May 12 in New York City. 

EXCLUSIVE: House Of Puff Launches Collaboration With Chris Wilson, Art Exhibition At NYC&#39;S Etain Cannabis Shop

RiverNorth Opportunities Fund, Inc. Common Stock

Rivernorth Opportunities Fund Inc

Rivian Automotive, Inc. - Class A Common Stock

Rivian Automotive Inc

Riviera Tool Co

Rivulet Media Inc Ordinary Shares

RIVEX TECHNOLOGY CORP by Rivex Technology Corp.

Rivex Technology Corp

RiverNorth Opportunities Fund, Inc. 6.00% Series A Perpetual Preferred Stock

DORM

Dorman Products Announced The Release Of Hundreds Of New Aftermarket Automotive Components And Assemblies

<ul>
<li>Patient Enrollment Has Accelerated with Now 10 Patients Enrolled in Phase 2 Trial.</li>
<li>6 out of 6 Patients Who Completed the 12-Week Treatment Have Chosen to Remain on TFF TAC by Proceeding to the Safety Extension Phase; 1 patient has been treated for over a year and 3 additional patients have been treated for more than 6 months.</li>
<li>Variability in Systemic Exposure to Tacrolimus Was Reduced with TFF TAC Which Could Lower Risk of Acute Rejection and Systemic Toxicities.</li>
</ul>

Biotech

Health Care

TFFP

TFF Pharmaceuticals Provided An Update From Its Ongoing Phase 2 Trial Of Tacrolimus Inhalation Powder For The Prevention Of Lung Transplant Rejection

Guidance

VERO

Venus Concept Expects Total Revenue For Q2 Of At Least $16.5M Vs. 17.54M Estimate

David will join Compugen from Oramed Pharmaceuticals Inc., where he served as Chief Financial Officer.

Management

CGEN

ORMP

Compugen Appoints David Silberman As Its New CFO Effective August 15, 2024, Taking Over From Alberto Sessa Who Will Depart On The Same Day

CREX

Creative Realities Announces Its Development Of A Channel Program Tailored And Targeted To The EMEA Marketplace

Mizuho analyst Dan Dolev maintains Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) with a Neutral and lowers the price target from $129 to $105.

Price Target

Analyst Ratings

Mizuho Maintains Neutral on Global Payments, Lowers Price Target to $105

Updated 2024 Annual Financial Outlook
Sportradar is raising its fiscal 2024 outlook for revenue and Adjusted EBITDA (non-IFRS) as follows:
<ul>
<li>Revenue of &euro;1,060 million compared with prior outlook of &euro;1,050 million, up 21% year-over-year and representing a 1-percentage point improvement in our full year growth rate.</li>
<li>Adjusted EBITDA (non-IFRS) of at least &euro;202 million compared with prior outlook of &euro;200 million, up 21% and representing a 1-percentage point improvement in our full year growth rate.</li>
<li>Adjusted EBITDA margin (non-IFRS) of approximately 19%.</li>
</ul>

Earnings

SRAD

Sportradar 2024 Outlook: Expects Revenue Of €1.06B (Prior €1.05B) Vs. €1.054B; Sees Adjusted EBITDA Off At Least €202M (Prior €200M)

TRAK

ReposiTrak Disclosed That They Added 20 New Produce Suppliers To The Queue For The Rapidly Expanding Food Traceability Network

CABA

Cabaletta Bio Expects That Its Cash, Cash Equivalents And Short-term Investments Of $223.8M As Of March 31, 2024, Will Enable It To Fund Its Operating Plan Into The First Half Of 2026.

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Gain Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GANX#NASDAQ">GANX</a>) with a Buy and maintains $9 price target.

Reiteration

GANX

HC Wainwright & Co. Reiterates Buy on Gain Therapeutics, Maintains $9 Price Target

Acurx Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACXP#NASDAQ">ACXP</a>) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.24) by 16.67 percent. This is a 12 percent decrease over losses of $(0.25) per share from the same period last year.

Earnings Misses

ACXP

Acurx Pharmaceuticals Q1 2024 GAAP EPS $(0.28) Misses $(0.24) Estimate

OLMA

Olema Oncology Announces Interim Results From Phase 1b/2 Palazestrant Study, Says 85% Clinical Benefit Rate Observed To Date Across All CBR-Eligible Patients

Mizuho analyst Ben Chaiken maintains Cedar Fair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUN#NYSE">FUN</a>) with a Buy and lowers the price target from $56 to $55.

Mizuho Maintains Buy on Cedar Fair, Lowers Price Target to $55

Buybacks

RSKD

Riskified Authorized Repurchase Of An Additional $75M Of Ordinary Shares Subject To Completion Of Required Israeli Regulatory Procedures; Company's Total Outstanding Aggregate Repurchase Authorization Is Approximately $92M As Of May 10

Cabaletta Bio Q1 2024 GAAP EPS $(0.51) Misses $(0.47) Estimate

SATS

Echostar Announced They Have Been Awarded An Indefinite Delivery, Indefinite Quantity Contract As Part Of The U.S. Naval Supply Systems Command Spiral 4 Wireless Products And Services Purchasing Program

The integration involves a commercial Class 6 chassis cab with an industry proven electric propulsion system powered by Plug&#39;s&nbsp;ProGen fuel cell technology and seamlessly integrated with an industry proven electric propulsion system. The product is currently in its final integration and testing phase and is expected to commence on-road operational pilots this summer in collaboration with Plug&#39;s key market leader logistics customers.

PLUG

Plug Power Reveals Integration Of Class 6, Medium-Duty Fuel Cell Electric Truck

Mizuho analyst Anthony Petrone maintains Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) with a Buy and raises the price target from $85 to $90.

Mizuho Maintains Buy on Boston Scientific, Raises Price Target to $90

WIIM

IPWR

iPower shares are trading higher after the company reported better-than-expected Q3 financial results.

Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Coupang</h3>
<ul>
<li>The Trade: Coupang, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>) Director Neil Mehta <a href="https://www.benzinga.com/quote/CPNG/analyst-ratings">acquired a total of 918,789 shares</a> at an average price of $22.19. To acquire these shares, it cost around $20.39 million.</li>
<li>What's Happening: On May 7, Coupang posted mixed first-quarter financial results.</li>
<li>What Coupang Does: Coupang Inc is an e-commerce company. It sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Developing Offerings.</li>
</ul>
<h3 class="wp-block-heading">Vestis</h3>
<ul>
<li>The Trade: Vestis Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) EVP and CFO Ricky T Dillon acquired a total of 16,200 shares at an average price of $12.43. To acquire these shares, it cost around $201,320.</li>
<li>What's Happening: On May 7, Redburn Atlantic analyst Oliver Davies downgraded Vestis from Buy to Neutral.</li>
<li>What Vestis Does: Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada.</li>
</ul>
Don&#8217;t forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<h3 class="wp-block-heading">Akamai Technologies</h3>
<ul>
<li>The Trade: Akamai Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAM#NASDAQ">AKAM</a>) CEO F Thomson Leighton <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 22,000 shares</a> at an average price of $92.68. To acquire these shares, it cost around $2.04 million.</li>
<li>What's Happening: On May 9, Akamai issued weak guidance.</li>
<li>What Akamai Technologies Does: Akamai operates a content delivery network, or CDN, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/earnings/24/05/38835371/cisco-prestige-consumer-healthcare-and-3-stocks-to-watch-heading-into-wednesday">Cisco, Prestige Consumer Healthcare And 3 Stocks To Watch Heading Into Wednesday</a>

Long Ideas

Insider Trades

Pre-Market Outlook

Trading Ideas

AKAM

CPNG

VSTS

Over $20M Bet On Coupang? Check Out These 3 Stocks Insiders Are Buying

5 High Yield CEFs That Raised Distributions In 2024

These 7 High-Yield CEFs Reduced Distributions In 2024, Consider Buying Anyway

RIV: Increase Your Cash Stream With RiverNorth's 13.5% Level Distribution

How To Save For Retirement Using The Income Compounder Approach

RIV: Attractive Discount, But Could Get More Attractive

RiverNorth Opportunities Fund declares $0.1289 dividend

ACV: Improving Diversification, But Valuation Ignores Distribution Risks (Downgrade)

CSQ: Increasing Exposure To Magnificent 7 Bad For Diversification

Top 10 Holdings In My 15% Yielding Income Compounder Portfolio

FT: Underappreciated CEF Well Positioned For Net Zero And The Provision Of Income

ASGI

BCAT

BXSY

CCIF

CEFS

ECAT

ICVT

OCCI

OXLC

PSHZF

SOUHY

TLTW

Press Releases

RiverNorth Closed-End Funds Declare Monthly Distributions

RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc. Announce Preferred Dividends

RFMZ

RMMZ

Riviera Holdings